Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Octapharma AG 

Seidenstraße 2

Lachen    CH-8853  Switzerland
Phone: 41-55-451-2121 Fax: 41-55-451-2110



 Company News
Octapharma AG Announces Octagam® 10% Now Available For Ordering In U.S. 10/27/2014 10:55:41 AM
European Commission (EC) Publishes Approval Of Octapharma AG’s Human Cell Line Recombinant FVIII (Nuwiq®) Across All Age Groups In Haemophilia A 8/6/2014 10:12:06 AM
Octapharma AG Sponsors Symposium “Spotlight On The Human Factor: Building A Foundation For The Future Of Haemophilia A Management" At 2014 WFH World Congress In Melbourne, Australia 5/27/2014 7:08:02 AM
Octapharma AG Phase 2/3 Trial For The Targeted Treatment Of Relapsing Multiple Sclerosis Enrols First Patients 12/18/2013 9:32:30 AM
Octapharma AG Enters Into Agreement With Pfizer Inc. (PFE) For The Future Commercialization And Marketing In The U.S. Of An Investigational Intravenous Therapy For The Urgent Reversal Of An Oral Anticoagulant 12/11/2013 9:48:06 AM
Octapharma AG Leading Corporate Sponsor of Save One Life 5/30/2013 10:35:28 AM
FDA Approves Octaplas® Expanding Octapharma USA, Inc.'s Transfusion Medicine Therapies 1/18/2013 8:02:53 AM
Octapharma AG Sponsors Educational Programs, Presents Research at the 64th Annual NHF Meeting in Orlando 11/7/2012 10:05:22 AM
Octapharma AG Opens $32 Million Recombinant Research Facility in Heidelberg 9/28/2012 7:11:45 AM
Octapharma AG Hosts Symposium at World Federation of Hemophilia World Congress on "Personalizing the Inhibitor Treatment and Prevention" in Hemophilia A 7/25/2012 10:15:36 AM